Sanofi (FRA:SNW2)

Market Cap	95.74B -22.4%
Revenue (ttm)	46.72B +5.5%
Net Income	7.81B +40.5%
EPS	6.40 +44.2%
Shares Out	n/a
PE Ratio	12.25
Forward PE	9.46
Dividend	1.42 (3.65%)
Ex-Dividend Date	May 9, 2025

Volume	n/a
Average Volume	9
Open	38.40
Previous Close	38.40
Day's Range	38.20 - 38.40
52-Week Range	38.20 - 54.50
Beta	n/a
RSI	41.86
Earnings Date	Jan 29, 2026

About Sanofi

Sanofi engages in the research, development, manufacture, and marketing of therapeutic solutions. It provides immunology and inflammation, rare diseases, neurology, oncology, and other medicines and vaccines. It also offers poliomyelitis, pertussis, and haemophilus influenzae type b (Hib) pediatric vaccines; respiratory syncytial virus protection and hexavalent combination vaccines protecting against diphtheria, tetanus, pertussis, polio, Hib, and hepatitis B; influenza, booster, meningitis, and travel and endemic vaccines, that includes hepati...

• Industry: Pharmaceutical Preparations
• Founded: 1994
• Employees: 82,878
• Stock Exchange: Frankfurt Stock Exchange
• Ticker Symbol: SNW2

Financial Performance

In 2025, Sanofi's revenue was 46.72 billion, an increase of 5.49% compared to the previous year's 44.29 billion. Earnings were 7.81 billion, an increase of 40.52%.